As of Jul 21
| +0.21 / +0.65%|
The 22 analysts offering 12-month price forecasts for Teva Pharmaceutical have a median target of 38.00, with a high estimate of 50.00 and a low estimate of 28.00. The median estimate represents a +16.42% increase from the last price of 32.64.
The current consensus among 27 polled investment analysts is to Hold stock in Teva Pharmaceutical. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.